Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BMY:NYQ since
announced
Transaction
value
RayzeBio IncDeal completed26 Dec 202326 Dec 2023Deal completed12.58%4.21bn
Karuna Therapeutics IncDeal completed22 Dec 202322 Dec 2023Deal completed14.85%14.40bn
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
Mercer Global Investments Europe Ltd.as of 31 Dec 2023203.43k0.01%
UBS Asset Management Switzerland AGas of 31 Dec 202332.30k0.00%
BRAM - Bradesco Asset Management SA DTVMas of 30 Jun 20244.63k0.00%
Data from 28 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.